Editors' Pick

Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.

Ryu C H, Park K Y, Hou Y, Jeong C H, Kim S M, Jeun S-S

Biomed Res Int. 2013; 2013:696738. Epub 2013 Apr 22. PMID: 23710456. Abstract

Editors' Pick

Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.

Boyd A, Zhang H, Williams A

Acta Neuropathol. 2013 Apr 18. Epub 1969 Dec 31. PMID: 23595275. Abstract

Papers: 8 Apr 2013 - 15 Apr 2013

Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation.

Biomarkers: Foretelling the Future

"San Diego palm trees sidewalk piers" by Jon Sullivan

American Academy of Neurology meeting report

Predicting whether patients will progress to disability—and how they will respond to treatments—are...

Clinical Research, Meetings

Editors' Pick

Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.

Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, et al.

PLoS Pathog. 2013 Apr; 9(4):e1003220. Epub 2013 Apr 11. PMID: 23592979. Abstract

Editors' Pick

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.

Kalincik T, Guttmann CRG, Krasensky J, Vaneckova M, Lelkova P, Tyblova M, Seidl Z, De Jager PL, Havrdova E, Horakova D

Genes Immun. 2013 Apr 11. Epub 2013 Apr 11. PMID: 23575354. Abstract

Editors' Pick

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.

Gold R, Giovannoni G, Selmaj K, Havrdova E, Montalban X, Radue E-W, Stefoski D, Robinson R, Riester K, Rana J, et al.

Lancet. 2013 Apr 3. Epub 1969 Dec 31. PMID: 23562009. Abstract

Papers: 1 Apr 2013 - 8 Apr 2013

Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation.

Editors' Pick

Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.

Kurnellas MP, Adams CM, Sobel RA, Steinman L, Rothbard JB

Sci Transl Med. 2013 Apr 3; 5(179):179ra42. PMID: 23552370. Abstract

Evidence Grows for Pathogenic Antibody

American Academy of Neurology meeting report

For years, MS researchers have searched in vain for a holy grail: a protein target...

Laboratory Research, Meetings

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Papers: 8 Apr 2013 - 15 Apr 2013

Biomarkers: Foretelling the Future

Papers: 1 Apr 2013 - 8 Apr 2013

Evidence Grows for Pathogenic Antibody

Pages

MSDF Footer

Search form

Papers: 8 Apr 2013 - 15 Apr 2013

Papers: 1 Apr 2013 - 8 Apr 2013

Pages